David Einhorn – TLIS history
- Issuer:
- TALIS BIOMEDICAL CORP
- Quarters tracked:
- 10 (Q4 2021 → Q4 2023)
- Current shares:
- 149,052
- Current value:
- $1.11M
- Peak shares:
- 2,235,783 (Q1 2022)
- Overall change:
- -91%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q4 2023 | 149,052 | $1.11M | $7.45 | 0 | 0% |
| Q4 2023 | 149,052 | $1.11M | $7.45 | 0 | 0% |
| Q3 2023 | 149,052 | $860K | $5.77 | -2,086,731 | -93% |
| Q2 2023 | 2,235,783 | $1.07M | $0.48 | 0 | 0% |
| Q1 2023 | 2,235,783 | $1.10B | $490.00 | 0 | 0% |
| Q4 2022 | 2,235,783 | $997K | $0.45 | 0 | 0% |
| Q3 2022 | 2,235,783 | $1.52M | $0.68 | 0 | 0% |
| Q2 2022 | 2,235,783 | $1.82M | $0.81 | 0 | 0% |
| Q1 2022 | 2,235,783 | $3.15M | $1.41 | +666,483 | +42% |
| Q4 2021 | 1,569,300 | $6.29M | $4.01 | — | NEW |